Clinical Trials Browser

Phase 1/2 × Sarcoma, Ewing × regorafenib × Clear all

NCT05395741 2026-03-25

Regbone

Phase 1/2 Active not recruiting

Bone Neoplasms, Sarcoma, Ewing, Osteosarcoma